| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |